Artocarpus lakoocha

Artocarpus lakoocha contains oxyresveratrol, prenylated flavonoids (including artocarpin), catechins, and phenolic compounds that exert antioxidant, anti-inflammatory, and antibacterial effects through free radical scavenging, inhibition of eicosanoid signaling, and disruption of bacterial cell membranes. In vitro studies demonstrate that bark extracts achieve a minimum inhibitory concentration (MIC) of 0.16% w/v against methicillin-resistant Staphylococcus aureus (MRSA), while total phenolic content reaches 10.14 ± 0.72 g GAE/100 g extract in bark, representing the highest antioxidant capacity among tested plant parts.

Origin & History

Artocarpus lakoocha, commonly called monkey jackfruit or lakoocha, is native to the Indian subcontinent and Southeast Asia, distributed across Thailand, Myanmar, Bangladesh, India, and Malaysia, where it grows in tropical and subtropical forests at low to moderate elevations. The tree thrives in humid, well-drained soils and reaches up to 20 meters in height, producing large, rough-skinned fruits and yielding a reddish heartwood rich in stilbenoids. It has been cultivated near villages and in mixed-use agroforestry systems throughout its range, where all plant parts—bark, leaves, twigs, and fruit—are harvested for food and ethnomedicinal purposes.

Historical & Cultural Context

Artocarpus lakoocha has been integrated into the ethnomedicine of Thailand, India, Myanmar, and Bangladesh for centuries, where the bark and leaves are prepared as decoctions to manage diarrhea, fever, skin conditions, and inflammatory disorders, and the fruit is consumed both fresh and in fermented or pickled preparations. In Thailand, the plant holds particular significance as a component of traditional antidiarrheal and anti-inflammatory herbal formulas, and the sour, acidic fruit is used as a souring agent in local cuisine similar to tamarind. In Ayurvedic-adjacent traditions of eastern India and Bangladesh, the bark is applied topically for skin diseases and internally for digestive complaints, while the milky latex of the tree is used as a purgative and for topical wound care. The heartwood's reddish pigment containing oxyresveratrol has historically been exploited as a natural textile dye across the region, and more recently the same stilbenoid content has attracted commercial interest in cosmetic skin-brightening preparations in Southeast Asian markets.

Health Benefits

- **Antibacterial Activity**: Ethanolic bark extracts inhibit MRSA at an MIC of 0.16% w/v and Staphylococcus aureus at 1.25% w/v, with disk diffusion assays (750 µg/disk) confirming broad-spectrum activity including against Candida albicans at 2.50% w/v, suggesting membrane-disrupting or enzyme-inhibiting bactericidal mechanisms.
- **Antioxidant Protection**: Bark extracts yield DPPH scavenging activity of 7.19 ± 0.10 mg AEAC/g and twig extracts reach CUPRAC values of 92.53 ± 1.00 mg AEAC/g, reflecting potent free radical quenching driven by high phenolic (up to 10.14 g GAE/100 g) and flavonoid (up to 17.13 g QE/100 g) concentrations.
- **Anti-inflammatory Effects**: Oxyresveratrol and triterpenoids such as lupeol suppress arachidonic acid-derived eicosanoid synthesis and modulate redox signaling pathways, producing anti-inflammatory effects validated in animal models, though no human data are yet available.
- **Hepatoprotective Action**: Lupeol and stilbenoids from the heartwood and bark have demonstrated hepatoprotective activity in preclinical animal studies, likely through mitochondrial stabilization and reduction of oxidative stress in hepatocytes.
- **Anti-melanogenic (Skin-Lightening) Properties**: Oxyresveratrol from the heartwood inhibits tyrosinase enzyme activity, reducing melanin biosynthesis; this mechanism has made heartwood extracts of interest in cosmetic formulations for hyperpigmentation management.
- **Antidiarrheal Properties**: Traditional Thai use for diarrhea is supported by the high tannin content in bark and leaves, which can reduce intestinal motility and exert astringent effects on gut mucosa, though formal clinical validation is absent.
- **Antimicrobial and Antiviral Ethnomedicinal Uses**: Leaves and bark preparations are used across South and Southeast Asia against viral and parasitic infections including malaria; preliminary in vitro data support antiviral and antimalarial bioactivity, with specific prenylated flavonoids like artocarpin implicated as active agents.

How It Works

Oxyresveratrol, a stilbenoid concentrated in the heartwood and bark, exerts its effects primarily through tyrosinase enzyme inhibition (reducing melanin synthesis), suppression of cyclooxygenase (COX)-mediated arachidonic acid conversion to pro-inflammatory eicosanoids, mitochondrial membrane stabilization, and direct electron donation to quench reactive oxygen species (ROS). Artocarpin and other prenylated flavonoids interact with inflammatory signaling cascades, potentially inhibiting NF-κB pathway activation and downstream cytokine production, as suggested by in vitro anti-inflammatory models. Tannins present in bark and leaves act through protein-precipitating astringency, disrupting bacterial cell surface proteins and reducing intestinal secretion, which underpins the antidiarrheal ethnomedicinal application. Lupeol, a triterpenoid identified in the plant, contributes hepatoprotective effects by modulating oxidative stress markers and stabilizing hepatocyte mitochondrial function in preclinical rodent models.

Scientific Research

The current evidence base consists entirely of in vitro biochemical assays and limited animal studies, with zero registered human clinical trials identified in the published literature as of the latest available data. Phytochemical and antioxidant studies have employed standardized assays (DPPH, CUPRAC, FRAP) across multiple plant parts, providing quantitative, reproducible data on phenolic and flavonoid content, but these findings cannot be extrapolated to therapeutic doses in humans without pharmacokinetic bridging studies. Antibacterial studies using disk diffusion and MIC determination against clinically relevant pathogens including MRSA provide proof-of-concept data, but in vitro MIC values are routinely many-fold lower than achievable in vivo concentrations. No dose-response studies in animal models with defined NOAEL or LOAEL values have been reported, and the absence of toxicology, bioavailability, and pharmacokinetic data represents the most significant translational gap preventing clinical development.

Clinical Summary

No clinical trials in human subjects have been conducted on Artocarpus lakoocha extracts or isolated compounds for any indication, making a formal clinical summary impossible at this stage. All efficacy data derive from in vitro cell-free assays, bacterial culture studies, and a small number of preclinical rodent models examining anti-inflammatory and hepatoprotective endpoints without published effect sizes or statistical confidence intervals suitable for clinical interpretation. The most robust preclinical findings concern antibacterial activity against MRSA (MIC 0.16% w/v) and antioxidant capacity of bark extracts, yet these have not been replicated in animal infection models or progressed to Phase I safety evaluation. Confidence in any specific clinical benefit remains very low and requires prospective pharmacokinetic, toxicological, and ultimately randomized controlled trial investigation before therapeutic claims can be substantiated.

Nutritional Profile

Per 100 g of fresh Artocarpus lakoocha fruit: moisture approximately 75.5%, protein ~0.24 g, fat ~0.63 g, crude fiber ~2.47 g, and vitamin C ~13.4 mg; carbohydrate content is not precisely reported but inferred from the remaining mass fraction. The fruit is not a significant source of macronutrients compared to staple foods but contributes dietary fiber and modest ascorbic acid. Phytochemically, the most nutritionally and pharmacologically relevant constituents are oxyresveratrol (stilbenoid), artocarpin and related prenylated flavonoids, (epi)catechin (flavan-3-ol), β-sitosterol (phytosterol), and hydrolyzable tannins. Bark extracts are particularly rich in total phenolics (10.14 ± 0.72 g GAE/100 g) and leaves in total flavonoids (17.13 ± 1.77 g QE/100 g); bioavailability of these compounds from oral consumption is unquantified and likely varies substantially depending on food matrix, extraction method, gut microbiome metabolism, and first-pass hepatic processing.

Preparation & Dosage

- **Traditional Oral Preparation (Bark Decoction)**: Bark is boiled in water and consumed as a decoction for antidiarrheal and anti-inflammatory purposes in Thai folk medicine; no standardized volume or concentration has been established.
- **Ethanolic Bark Extract (Pharmacological Research Form)**: Prepared by maceration in 95% ethanol, yielding extracts with total phenolics up to 10.14 g GAE/100 g; used in laboratory studies but no human dose established.
- **Methanolic/Ethanolic Fruit Extract**: Fruits macerated in methanol or ethanol for isolation of lakoochamide, oxyresveratrol, (epi)catechin, and β-sitosterol; research-grade only.
- **Cosmetic Heartwood Extract (Oxyresveratrol-Enriched)**: Aqueous or hydroalcoholic extracts of heartwood standardized for oxyresveratrol content are used in topical skin-lightening cosmetic formulations; concentrations vary by manufacturer with no regulatory standard.
- **Fresh Fruit (Culinary)**: Consumed raw or in traditional dishes in Southeast Asia; provides ~13.4 mg vitamin C per 100 g and crude fiber ~2.47%, with no defined therapeutic dose.
- **No Standardized Supplement Dose**: No clinically validated oral supplement dose exists; any formulation marketed with health claims lacks clinical dose-finding support and should be approached with caution.

Synergy & Pairings

Oxyresveratrol from Artocarpus lakoocha may exhibit additive or synergistic antioxidant effects when combined with other polyphenol-rich botanicals such as green tea catechins (EGCG) or grape-derived resveratrol, as these compounds act through complementary radical scavenging and redox-signaling mechanisms. Tannin-rich bark preparations used for antidiarrheal purposes may synergize with probiotic interventions that restore gut flora balance, as tannins address the pathogenic bacterial burden while probiotics support mucosal recovery. In cosmetic applications, oxyresveratrol-enriched heartwood extracts are frequently paired with vitamin C (ascorbic acid) in skin-lightening formulations, as both inhibit tyrosinase through different binding sites, producing a combined depigmentation effect greater than either agent alone.

Safety & Interactions

Formal safety data for Artocarpus lakoocha extracts in humans are entirely absent; no NOAEL, LOAEL, acute toxicity LD50, or subchronic toxicity values have been established in peer-reviewed literature, and no adverse event reports from clinical use have been published. Animal toxicological studies have not been reported, meaning the safe dose range, organ toxicity profile, and reproductive or developmental safety are completely unknown, warranting significant caution with any supplemental use above typical dietary fruit consumption. No drug interaction studies have been conducted; however, the presence of potent antioxidant and COX-pathway-modulating compounds theoretically raises concern for interactions with anticoagulants (e.g., warfarin), nonsteroidal anti-inflammatory drugs, and immunosuppressants, though this is speculative without empirical data. Pregnancy and lactation safety are undetermined; given the purgative traditional use of latex and the lack of reproductive toxicology data, use beyond culinary fruit consumption is not advisable during pregnancy or breastfeeding.